BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 383617)

  • 1. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
    Bortolussi R; Ferrieri P; Björkstén B; Quie PG
    Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    Björkstén B; Bortolussi R; Gothefors L; Quie PG
    J Pediatr; 1976 Dec; 89(6):892-7. PubMed ID: 792409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Weiss J; Victor M; Cross AS; Elsbach P
    Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.
    Agüero ME; Cabello FC
    Infect Immun; 1983 Apr; 40(1):359-68. PubMed ID: 6339405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.
    Pluschke G; Mayden J; Achtman M; Levine RP
    Infect Immun; 1983 Dec; 42(3):907-13. PubMed ID: 6196296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
    Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J
    Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.
    Allen PM; Roberts I; Boulnois GJ; Saunders JR; Hart CA
    Infect Immun; 1987 Nov; 55(11):2662-8. PubMed ID: 3312006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG.
    Lassiter HA; Christensen RD; Parker CJ
    J Infect Dis; 1989 Mar; 159(3):518-25. PubMed ID: 2644382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
    Allen PM; Fisher D; Saunders JR; Hart CA
    J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.
    Pluschke G; Achtman M
    Infect Immun; 1984 Feb; 43(2):684-92. PubMed ID: 6198283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of capsular polysaccharide determines serum resistance in Escherichia coli K92.
    Suerbaum S; Friedrich S; Leying H; Opferkuch W
    Zentralbl Bakteriol; 1994 Aug; 281(2):146-57. PubMed ID: 7858342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-mediated killing, opsonization, and serum-mediated killing of Escherichia coli K1 by neonatal rats.
    Lassiter HA; Christensen RD; Parker C; Rothstein G
    Biol Neonate; 1988; 53(3):156-62. PubMed ID: 3285898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.
    Cisowska A; Jankowski S
    Folia Microbiol (Praha); 2004; 49(4):471-8. PubMed ID: 15530015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of various capsular (K) E. coli by the alternative complement pathway.
    Stevens P; Young LS; Adamu S
    Immunology; 1983 Nov; 50(3):497-502. PubMed ID: 6354922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.